focus -WSS

focus

author：knowledge 2025-09-30 18:54:06 - browse：2291

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

LONDON — A U.K. government agency on Tuesday said that it won’t recommend Eli Lilly’s Mounjaro — part of a new class of medications that help patients lose weight — for people with type 2 diabetes without additional evidence.

Mounjaro, also known as tirzepatide, has U.S. approval for type 2 diabetes and is expected to win the regulatory green light for obesity later this year. It is one of several medications, along with Wegovy and Ozempic from Novo Nordisk, that have shown dramatic weight loss results, creating a surge in demand and blockbuster sales expectations.

But in draft guidance, the U.K.’s National Institute for Health and Care Excellence, which assesses the cost-effectiveness of medications, said it had asked Lilly for more data “to address the uncertainties in the clinical evidence, when compared to all relevant alternative treatments.” NICE recommendations are used by the National Health Service to determine whether to provide certain medications.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： First recipient of genetically engineered pig kidney has died

Wikipedia

WSS

Steward Health Care files for bankruptcy

As Maui death toll rises, number of missing remains unclear

Study: People of West African ancestry at greater risk of cardiac amyloidosis

Making AI in medicine accessible to smaller, and rural hospitals

An interview with Robert F. Kennedy Jr. on vaccines

Sanofi strikes deal with Novavax, boosting the vaccine maker

knowledge

focus

Wikipedia

Alkermes shareholders re

Hilary expected to bring catastrophic, life

Medical leaders decry Supreme Court decision on affirmative action

First recipient of genetically engineered pig kidney has died

Duchenne breakthrough therapy leaves behind pioneering families

Apple Watch's A

In Memoriam: Notable people who died in 2023

The pain doctors face in trying to build their families

BioMarin wins approval for gene therapy to treat hemophilia A

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

hotspot

Hilary expected to bring catastrophic, life

Eye stem cell transplant could help restore vision in injured people

New details revealed about Purdue's marketing of OxyContin

The boys, now 6, who are gene therapy’s ‘edge case’ problem

Steward Health Care files for bankruptcy

After gene therapy, two congenitally deaf children hear for the first time

Wikipedia

knowledge

hotspot

knowledge